Krsnaa Diagnostics Ltd Stock Price Today (NSE: KRSNAA)
Fundamental Score
Krsnaa Diagnostics Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Krsnaa Diagnostics Ltd share price today is ₹670.55, up +0.00% on NSE/BSE as of 17 February 2026. Krsnaa Diagnostics Ltd (KRSNAA) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹2.63K (Cr). The 52-week high for KRSNAA share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 30.73x, KRSNAA is currently trading below its industry average P/E of 39.28x. The company has a Return on Equity (ROE) of 9.29% and a debt-to-equity ratio of 0.30.
Krsnaa Diagnostics Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Krsnaa Diagnostics Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Krsnaa Diagnostics Share Price Analysis: A Growth Strategist's Perspective
The Healthcare Service Provider industry is undergoing a significant transformation, driven by increasing demand for accessible and affordable diagnostics, particularly in Tier 2 and Tier 3 cities. This shift creates opportunities for companies leveraging technology and efficient operational models. This financial analysis offers observations on the current standing of Krsnaa Diagnostics share price, aiming to understand its positioning within this evolving landscape.
Currently trading at ₹700.799988, Krsnaa Diagnostics boasts a PE ratio of 30.73. This valuation suggests investor expectations are high regarding future earnings growth. When compared to its sector peers like
Suraksha Diagnostic Ltd, it is crucial to examine management quality and its impact on sustainable expansion. While objective metrics are important, a qualitative assessment of management's vision, execution capabilities, and corporate governance practices is equally critical for assessing long-term value creation. The long-term health of Krsnaa Diagnostics requires a leadership team capable of navigating the complexities of the Indian healthcare market.A key indicator of Krsnaa Diagnostics' competitive advantage is its Return on Capital Employed (ROCE) of 12.52%. ROCE illustrates how efficiently the company generates profits from its capital investments. A higher ROCE generally signals a stronger moat. However, in a rapidly growing sector, maintaining and improving ROCE is vital. A consistently high ROCE, especially when compared to sector averages, indicates the potential for sustainable profitability and reinvestment opportunities, strengthening the company's long-term financial position and ability to deliver value to shareholders.
This analysis is part of a comprehensive, 80-parameter fundamental audit. The meticulous deep dive into Krsnaa Diagnostics was verified by Sweta Mishra. It is an observational assessment of publicly available information and should not be construed as financial advice. It provides context on the key financial ratios and competitive dynamics surrounding Krsnaa Diagnostics, enabling stakeholders to form their own informed opinions.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Krsnaa Diagnostics Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of KRSNAA across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Strong Operating Margins (26.91%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 30.73 vs Industry: 39.28)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Consistent Growth Track Record (21.41% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (16.14% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (22.05% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.30)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (5.20x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Below-Average Return on Equity (9.29%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Negative Free Cash Flow (₹-202.11 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Low Promoter Commitment (27.11%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
Krsnaa Diagnostics Ltd Financial Statements
Comprehensive financial data for Krsnaa Diagnostics Ltd including income statement, balance sheet and cash flow
About KRSNAA (Krsnaa Diagnostics Ltd)
Krsnaa Diagnostics Ltd (KRSNAA) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Healthcare Service Provider sector with a current market capitalisation of ₹2.63K (Cr). Krsnaa Diagnostics Ltd has delivered a Return on Equity (ROE) of 9.29% and a ROCE of 12.52%. The debt-to-equity ratio stands at 0.30, reflecting the company's capital structure. Investors tracking KRSNAA share price can monitor key metrics including P/E ratio, promoter holding of 27.11%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
Latest News
KRSNAA Share Price: Frequently Asked Questions
What is the current share price of Krsnaa Diagnostics Ltd (KRSNAA)?
As of 17 Feb 2026, 10:14 am IST, Krsnaa Diagnostics Ltd share price is ₹670.55. The KRSNAA stock has a market capitalisation of ₹2.63K (Cr) on NSE/BSE.
Is KRSNAA share price Overvalued or Undervalued?
KRSNAA share price is currently trading at a P/E ratio of 30.73x, compared to the industry average of 39.28x. Based on this relative valuation, the Krsnaa Diagnostics Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of KRSNAA share price?
The 52-week high of KRSNAA share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Krsnaa Diagnostics Ltd share price?
Key factors influencing KRSNAA share price include quarterly earnings growth (Sales Growth: 2.33%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Krsnaa Diagnostics Ltd a good stock for long-term investment?
Krsnaa Diagnostics Ltd shows a 5-year Profit Growth of 22.05% and an ROE of 9.29%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.30 before investing in KRSNAA shares.
How does Krsnaa Diagnostics Ltd compare with its industry peers?
Krsnaa Diagnostics Ltd competes with major peers in the Healthcare Service Provider. Investors should compare KRSNAA share price P/E of 30.73x and ROE of 9.29% against the industry averages to determine competitive standing.
What is the P/E ratio of KRSNAA and what does it mean?
KRSNAA share price has a P/E ratio of 30.73x compared to the industry average of 39.28x. Investors pay ₹31 for every ₹1 of annual earnings.
How is KRSNAA performing according to Bull Run's analysis?
KRSNAA has a Bull Run fundamental score of 39.6/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does KRSNAA belong to?
KRSNAA operates in the Healthcare Service Provider industry. This classification helps understand the competitive landscape and sector-specific trends affecting Krsnaa Diagnostics Ltd share price.
What is Return on Equity (ROE) and why is it important for KRSNAA?
KRSNAA has an ROE of 9.29%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Krsnaa Diagnostics Ltd generates profits from shareholders capital.
How is KRSNAA debt-to-equity ratio and what does it indicate?
KRSNAA has a debt-to-equity ratio of 0.30, which indicates conservative financing with low financial risk.
What is KRSNAA dividend yield and is it a good dividend stock?
KRSNAA offers a dividend yield of 0.34%, meaning you receive ₹0.34 annual dividend for every ₹100 invested in Krsnaa Diagnostics Ltd shares.
How has KRSNAA share price grown over the past 5 years?
KRSNAA has achieved 5-year growth rates of: Sales Growth 21.41%, Profit Growth 22.05%, and EPS Growth 16.14%.
What is the promoter holding in KRSNAA and why does it matter?
Promoters hold 27.11% of KRSNAA shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Krsnaa Diagnostics Ltd.
What is KRSNAA market capitalisation category?
KRSNAA has a market capitalisation of ₹2626 crores, placing it in the Small-cap category.
How volatile is KRSNAA stock?
KRSNAA has a beta of N/A. A beta > 1 suggests the Krsnaa Diagnostics Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is KRSNAA operating profit margin trend?
KRSNAA has a 5-year average Operating Profit Margin (OPM) of 26.91%, indicating the company's operational efficiency.
How is KRSNAA quarterly performance?
Recent quarterly performance shows Krsnaa Diagnostics Ltd YoY Sales Growth of 2.33% and YoY Profit Growth of 5.78%.
What is the institutional holding pattern in KRSNAA?
KRSNAA has FII holding of 3.66% and DII holding of 14.96%. Significant institutional holding often suggests professional confidence in the Krsnaa Diagnostics Ltd stock.